Morphofunctional state of platelets in their concentrates depending on storage time
- Authors: Khabirova A.I.1, Fatkhullina L.S.2, Andrianova I.A.1, Evtugina N.G.1, Litvinov R.I.1
-
Affiliations:
- Institute of Fundamental Medicine and Biology
- Interregional Clinical Diagnostic Center
- Issue: Vol 104, No 2 (2023)
- Pages: 249-260
- Section: Experimental medicine
- URL: https://kazanmedjournal.ru/kazanmedj/article/view/106739
- DOI: https://doi.org/10.17816/KMJ106739
- ID: 106739
Cite item
Open Access
Access granted
Abstract
Background. Evaluation of the functional state of platelets in the composition of concentrates is necessary to improve the methods of their production, optimize storage conditions and terms, increase therapeutic efficacy, and reduce the risk of transfusion complications.
Aim. Comprehensive study of the morphofunctional state of platelets during the storage of their concentrates.
Material and methods. 202 samples of human platelet apheresis concentrates were studied for storage periods of up to 1–7 days at a temperature of 22–24 °C. The functional state of platelets was assessed using flow cytometry for the expression of P-selectin, active αIIbβ3 integrin, and phosphatidylserines before and after biochemical stimulation. In addition, the mitochondrial potential of platelets, the concentration of intracellular adenosine triphosphate, contractile properties, induced aggregation, and morphological characteristics were studied according to scanning electron microscopy. Statistical analysis was performed by analysis of variance (ANOVA or Kruskal–Wallis).
Results. In non-activated platelets during storage, the spontaneous expression of P-selectin increased by an average of 7 times, and phosphatidylserines — by 3 times. The induced expression of P-selectin, integrin αIIbβ3 and phosphatidylserines was the highest on the day of receiving the concentrate and gradually decreased during storage to 1/2 of the initial level. Platelet aggregation activity in response to collagen stimulation progressively decreased by an average of 100 times, in response to the TRAP peptide — by 1.5 times. In contrast to the expression of activation markers, the ability of platelets to compress plasma clots in most samples changed slightly, within a few percent; in single samples, the contractile function dropped to zero by 4–7 days of storage, which was combined with platelet hyperactivation and depletion. The mitochondrial potential of platelets and the content of adenosine triphosphate were relatively constant. Morphologically, discoid platelets predominated, however, starting from the 1st day of storage, spindle-shaped platelets, and from the 3rd day — spherical forms and microaggregates of platelets accumulated.
Conclusion. Platelets in the composition of concentrates initially have a high functional potential, which gradually decreases due to progressive spontaneous activation with a simultaneous decrease in reactivity and structural changes.
Full Text
About the authors
Alina I. Khabirova
Institute of Fundamental Medicine and Biology
Author for correspondence.
Email: alina.urussu.95@gmail.com
ORCID iD: 0000-0002-7243-8832
ResearcherId: AAO-3282-2021
Junior Researcher, Research Laboratory “Protein-Cell Interactions”, Institute of Fundamental Medicine and Biology
Russian Federation, Kazan, RussiaLuciya S. Fatkhullina
Interregional Clinical Diagnostic Center
Email: Lusik65@rambler.ru
ORCID iD: 0000-0001-8303-7455
M.D., Head, Depart. of Procurement of Blood and Its Components
Russian Federation, Kazan, RussiaIzabella A. Andrianova
Institute of Fundamental Medicine and Biology
Email: izabella2d@gmail.com
ORCID iD: 0000-0003-3973-3183
Cand. Sci. (Biol.), Senior Researcher, Research Laboratory “Protein-Cell Interactions”, Institute of Fundamental Medicine and Biology
Russian Federation, Kazan, RussiaNatalia G. Evtugina
Institute of Fundamental Medicine and Biology
Email: natalja.evtugyna@gmail.com
ORCID iD: 0000-0002-4950-3691
PhD Stud., Depart. of Biochemistry, Biotechnology and Pharmacology, Institute of Fundamental Medicine and Biology
Russian Federation, Kazan, RussiaRustem I. Litvinov
Institute of Fundamental Medicine and Biology
Email: rustempa@gmail.com
ORCID iD: 0000-0003-0643-1496
M.D., D. Sci. (Med.), Prof., Chief Researcher, Research Laboratory “Protein-Cell Interactions”, Institute of Fundamental Medicine and Biology
Russian Federation, Kazan, RussiaReferences
- Estcourt LJ. Why has demand for platelet components increased? A review. Transfus Med. 2014;24(5):260–268. doi: 10.1111/tme.12155.
- Chechetkin AV, Danilchenko VV, Grigorjan MS, Vorobey LG, Plotskiy RA. The main indicators of activity of the blood service in the Russian Federation in 2017. Transfuziologiya. 2018;19(3):4–14. (In Russ.)
- Ng MSY, Tung JP, Fraser JF. Platelet storage lesions: what more do we know now? Transfus Med Rev. 2018;32(3):144–154. doi: 10.1016/j.tmrv.2018.04.001.
- Ignatova AA, Karpova OV, Trakhtman PE, Rumiantsev SA, Panteleev MA. Functional characteristics and clinical effectiveness of platelet concentrates treated with riboflavin and ultraviolet light in plasma and in platelet additive solution. Vox Sanguinis. 2016;110(3):244–252. doi: 10.1111/vox.12364.
- Karpova OV, Obraztsov IV, Trakhtman PE, Ignatova AA, Panteleev MA, Rumyantsev SA. Comparison of platelets characteristics according to various processing methods. Onkogematologiya. 2014;(4):37–45. (In Russ.)
- Fritsma GA. Platelet structure and function. Clinical Laboratory Science. 2015;28(2):125–131. doi: 10.29074/ascls.28.2.125.
- Litvinov RI, Peshkova AD. Contraction of blood clots and thrombi: pathogenic and clinical significance. Almanac of Clinical Medicine. 2018;46(7):662–671. (In Russ.) doi: 10.18786/2072-0505-2018-46-7-662-671.
- Zhiburt EB. Transfuziologiya. Uchebnik. (Transfusiology. Textbook.) SPb.: Piter; 2002. 736 p. (In Russ.)
- Melikyan AL, Pustoval EI, Tsvetaeva NV, Ptushkin VV , Gritsaev SV, Golenkov AK, Davydkin IL, Pospelova TI, Ivanova VL, Shatokhin YuV, Danishyan KI, Savchenko VG. National clinical recommendations for diagnosis and therapy of idiopathic thrombocytopenic purpura (primary immune thrombocytopenia) in adults (2016). Gematologiya i transfuziologiya. 2017;62(1-S1):1–24. (In Russ.)
- Protopopova AI, Gogolev NM, Tobokhov AV, Nikolaev VN, Neustroev PA, Timirdyaev DKh. Perelivanie komponentov, preparatov krovi i krovezameniteley. (Transfusion of components, blood products and blood substitutes.) М., Berlin: DirectMEDIA ; 2017. 169 p. (In Russ.)
- Wandt H, Schäfer-Eckart K, Greinacher A. Platelet transfusion in hematology, oncology and surgery. Dtsch Arztebl Int. 2014;111(48):809–815. doi: 10.3238/arztebl.2014.0809.
- Schlenke P, Sibrowski W. 2 platelet concentrates. Transfus Med Hemother. 2009;36(6):372–382. doi: 10.1159/000268058.
- Decree of the Government of the Russian Federation of June 22, 2019 No. 797 “On approval of the rules for the procurement, storage, transportation and clinical use of donated blood and its components and on the invalidation of certain acts of the government of the Russian Federation.” http://publication.pravo.gov.ru/Document/View/0001201907020007 (access date: 07.04.2022). (In Russ.)
- Van Der Meer PF, de Korte D. Platelet preservation: agitation and containers. Transfus Apher Sci. 2011;44(3):297–304. doi: 10.1016/j.transci.2011.03.005.
- Zhiburt EB, Madzaev SR. Organization of storage of blood components in the clinic. Glavnaya meditsinskaya sestra. 2014;(10):33–39. (In Russ.)
- Order of the Ministry of Health of Russia No. 1166n dated October 28, 2020 “On approval of the procedure for donors to undergo a medical examination and a list of medical contraindications (temporary and permanent) for donating blood and (or) its components and the timing of the withdrawal to which a person is subject in the presence of temporary medical indications, from the donation of blood and (or) its components.” https://legalacts.ru/doc/prikaz-minzdrava-rossii-ot-28102020-n-1166n-ob-utverzhdenii/ (access date: 07.04.2022). (In Russ.)
- Reddoch KM, Pidcoke HF, Montgomery RK, Fedyk CG, Aden JK, Ramasubramanian AK, Cap AP. Hemostatic function of apheresis platelets stored at 4 °C and 22 °C. Shock. 2014;41(Suppl 1 (01)):54–61. doi: 10.1097/SHK.0000000000000082.
- Sperling S, Vinholt PJ, Sprogoe U, Yazer MH, Frederiksen H, Nielsen C. The effects of storage on platelet function in different blood products. Hematology. 2019;24(1):89–96. doi: 10.1080/10245332.2018.1516599.
- Fiedler SA, Boller K, Junker AC, Kamp C, Hilger A, Schwarz W, Seitz R, Salge-Bartels U. Evaluation of the in vitro function of platelet concentrates from pooled buffy coats or apheresis. Transfus Med Hemother. 2020;47(4):314–325. doi: 10.1159/000504917.
- Singh S, Hakimi CS, Jeppsson A, Hesse C. Platelet storage lesion in interim platelet unit concentrates: A comparison with buffy-coat and apheresis concentrates. Transfus Apher Sci. 2017;56(6):870–874. doi: 10.1016/j.transci.2017.10.004.
- Jain A, Marwaha N, Sharma RR, Kaur J, Thakur M, Dhawan HK. Serial changes in morphology and biochemical markers in platelet preparations with storage. Asian J Transfus Sci. 2015;9(1):41–47. doi: 10.4103/0973-6247.150949.
- Zucker-Franklin D, Grusky G. The actin and myosin filaments of human and bovine blood platelets. J Clin Invest. 1972;51(2):419–430. doi: 10.1172/JCI106828.
- Perrotta PL, Perrotta CL, Snyder EL. Apoptotic activity in stored human platelets. Transfusion. 2003;43(4):526–535. doi: 10.1046/j.1537-2995.2003.00349.x.
Supplementary files
